Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 1.00 |
| ▸ | CA1 | P00915 | 8/20 | 1.00 |
| ▸ | CA9 | Q16790 | 6/20 | 1.00 |
| ▸ | CA12 | O43570 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.82 |
| ▸ | MEN1 | O00255 | 5/20 | 0.82 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.82 |
| ▸ | POLB | P06746 | 2/20 | 0.82 |
| ▸ | MAPT | P10636 | 2/20 | 0.82 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.82 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.82 |
| ▸ | RECQL | P46063 | 1/20 | 0.82 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.82 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.82 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.82 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.75 |
| ▸ | PLK1 | P53350 | 1/20 | 0.73 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18606712 | 0.85 | CA1 (1.00) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL14679075 | 0.84 | PRMT1 (0.77) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL8421687 | 0.83 | CA2 (0.84) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL6225517 | 0.83 | CA1 (0.84) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL95883 | 0.83 | CA2 (0.84) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL13980021 | 0.83 | CA1 (0.84) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL27468719 | 0.83 | CA2 (0.84) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL126415 | 0.83 | PTPN1 (0.87) | KMT2AMEN1POLBMAPTCACNA1B | |
| SCHEMBL3107195 | 0.83 | PRMT1 (0.75) | CA2CA1CA9CA12KMT2A | |
| SCHEMBL10327396 | 0.83 | PRMT1 (0.75) | CA2CA1CA9CA12KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660426-B | Method for rapidly determining various pesticide veterinary drug residues in animal-derived food and application | 山东杰诺检测服务有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-113030308-B | Detection method of sulfonamide antibiotics in biogas slurry and sample treatment method thereof | 浙江省农业科学院 | 2022-10-28 | — | — | CN | claimed |
| CN-110702805-B | UPLC-MSMS detection method for establishing 19 sulfanilamide residues in cultured fish based on ASE method of C18 | 舟山市食品药品检验检测研究院 | 2021-07-02 | — | — | CN | claimed |
| CN-108931599-B | Method for extracting and analyzing sulfonamides by using DPX gun head type dispersed solid phase microextraction column | 无锡微色谱生物科技有限公司 | 2021-06-01 | — | — | CN | claimed |
| CN-112858683-A | Method for simultaneously and rapidly detecting multiple antibiotics by using immunobiosensor | 清华大学 | 2021-05-28 | — | — | CN | claimed |
| CN-112595783-A | Method for detecting multiple antibiotics in livestock and poultry excrement based on magnetic nanocomposite | 山东省农业科学院农业质量标准与检测技术研究所 | 2021-04-02 | — | — | CN | claimed |
| CN-110702805-A | UPLC-MSMS detection method for establishing 19 sulfanilamide residues in cultured fish based on ASE method of C18 | 舟山市食品药品检验检测研究院 | 2020-01-17 | — | — | CN | claimed |
| EP-0573573-B1 | MESOGENIC GLYCIDYL AMINES | DOW CHEMICAL CO (US) | 1999-09-29 | — | — | EP | claimed |
| US-12269814-B2 | Process for preparing a compound useful to treat mycoses | PULMOCIDE LIMITED (GB) | 2025-04-08 | — | — | US | disclosed |
| CN-116773689-A | Method for rapidly screening various antibacterial drug residues in livestock manure and application thereof | 中国动物卫生与流行病学中心 | 2023-09-19 | — | — | CN | disclosed |
| US-11661415-B2 | Process for preparing a compound useful to treat mycoses | PULMOCIDE LIMITED (GB) | 2023-05-30 | — | — | US | disclosed |
| CN-116165316-A | Establishment method of 323 veterinary drug high-throughput screening mass spectrum database | 吉林大学 | 2023-05-26 | — | — | CN | disclosed |
| CN-113030308-B | Detection method of sulfonamide antibiotics in biogas slurry and sample treatment method thereof | 浙江省农业科学院 | 2022-10-28 | — | — | CN | disclosed |
| CN-114814013-A | Method for rapidly screening unknown chemical hazard residues in aquatic products based on high-resolution mass spectrum database | 中国海洋大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-1377282-A | Fatty acid-anticancer conjugates and uses thereof | PROTARGA INC (US) | 2002-10-30 | — | — | CN | disclosed |
| EP-0828488-A1 | ISOTHIAZOLONES | WARNER-LAMBERT COMPANY (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0775110-A1 | ARYLTHIO COMPOUNDS AS ANTIBACTERIAL AND ANTIVIRAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996038144-A1 | ISOTHIAZOLONES | WARNER-LAMBERT COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
| WO-1996004242-A1 | ARYLTHIO COMPOUNDS AS ANTIBACTERIAL AND ANTIVIRAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1996-02-15 | — | — | WO | disclosed |
| US-5463122-A | Amido-phenylthiols or dithiobisbenzamides as bactericides, viricides, retrovirus antigrowth agents; AIDS | WARNER-LAMBERT COMPANY (US) | 1995-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11661415-B2 | Process for preparing a compound useful to treat mycoses | DPM1, CYP51A1, ERG28 | CA2 3243/4885CA1 2628/4885CA9 239/4885 |
| US-12269814-B2 | Process for preparing a compound useful to treat mycoses | C1R, CBR1, CBR3 | CA2 633/4885CA1 2105/4885CA9 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.